Loading data
LRMRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 154.22 m USD | 73.28 m USD | 27.67 m USD | 24.25 m USD | 38.4 m USD |
| Operating profit | -172.5 m USD | -90.89 m USD | -41.76 m USD | -36.53 m USD | -50.47 m USD |
| Profit before tax | -165.67 m USD | -80.6 m USD | -36.95 m USD | -35.36 m USD | -50.64 m USD |
| Net income (reported basis) | -165.67 m USD | -80.6 m USD | -36.95 m USD | -35.36 m USD | -50.64 m USD |
| Basic earnings per share | — | -1.32 USD/share | -0.84 USD/share | -1.37 USD/share | -2.95 USD/share |
| Diluted earnings per share | — | -1.32 USD/share | -0.84 USD/share | -1.37 USD/share | -2.95 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.